Weatherford, TX, United States of America

Hans R Moll


Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1991-1994

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Hans R. Moll

Introduction

Hans R. Moll is a notable inventor based in Weatherford, TX (US). He has made significant contributions to the field of ophthalmology, particularly in methods for controlling intraocular pressure. With a total of 3 patents to his name, his work has the potential to impact the treatment of eye conditions significantly.

Latest Patents

Hans R. Moll's latest patents include innovative methods and compositions for controlling intraocular pressure. One of his patents discloses compositions and methods for controlling intraocular pressure using transition metal complexes. This patent highlights the topical ophthalmic and systemic administration of these transition metal complexes. Another significant patent focuses on methods for lowering elevated intraocular pressure resulting from the instillation of sodium hyaluronate during surgery. This method involves the administration of transition metal complexes, showcasing his commitment to advancing ophthalmic treatments.

Career Highlights

Hans R. Moll is currently associated with Alcon Laboratories, Inc., a leading company in eye care products. His work at Alcon has allowed him to develop and refine his innovative ideas, contributing to the company's mission of improving eye health.

Collaborations

Throughout his career, Hans has collaborated with talented individuals such as Mark T. Dupriest and Daniel Kuzmich. These collaborations have fostered an environment of innovation and creativity, further enhancing the impact of his work.

Conclusion

Hans R. Moll's contributions to ophthalmology through his patents and collaborations demonstrate his dedication to improving eye care. His innovative methods for controlling intraocular pressure are paving the way for advancements in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…